Despite usually non-existent profits, the biotechnology sector holds tremendous long-term opportunities
Advisors have different ideas and strategies to help this retired couple draw $10,000 annually from their limited savings
Yet it’s difficult to access these companies because they have few salable products or an identifiable market
Forty-one of 47 firms tracked by IE reported profits in the third quarter, and only nine saw their earnings decline from a year earlier
The economies of Canada and the U.S. are expected to grow at a healthy pace over the next two years, despite high oil prices, further increases in short-term interest rates and, in Canada’s case, a high dollar.Economists surveyed by Investment Executive may not form a consensus but collectively they expect U.S. economic growth to decelerate […]
The federal liberals’ recent flurry of pre-election spending announcements is affordable and mostly just fills in the details of initiatives announced in last February’s budget. But there is enough new that, should the Conservatives form the next government, that party will find itself constrained.At the top of the list is the $5.1 billion Prime Minister […]
Companies bulking up for anticipated growth
An aggressive investment strategy aimed at boosting returns can increase the risk beyond client’s comfort level
Fairfax aims for a 15% annual ROE
Aging populations and wonder drugs mean some global pharmaceutical companies will easily weather competition from generic foes